{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:29:50Z","timestamp":1787056190542,"version":"build-2736575974"},"reference-count":20,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>We present a case of a patient in her 70s with an 11-month history of Rai stage 1 chronic lymphocytic leukaemia (CLL) who presented to the emergency department with bilateral lower extremity weakness, frequent falls, urinary retention and incontinence worsening for 2\u2009weeks. Whole-spine MRI with and without contrast revealed continuous patchy and confluent enhancement from C1\u2013T10, consistent with lymphomatous infiltration. Lumbar puncture with flow cytometry demonstrated cerebrospinal fluid involvement of CLL. She started on zanubrutinib with an excellent clinical response. Follow-up whole-spine MRI after 12 weeks of therapy revealed resolution of prior areas of abnormal enhancement. Central nervous system (CNS) involvement in CLL is rare and can cause debilitating symptoms. New neurologic symptoms in patients with a known CLL history should prompt investigation to assess for transformation and CNS involvement. Treatment with a Bruton tyrosine kinase inhibitor such as zanubrutinib or a venetoclax-based regimen may be necessary.<\/jats:p>","DOI":"10.1136\/bcr-2026-274800","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:55:24Z","timestamp":1787054124000},"page":"e274800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Central nervous system involvement of chronic lymphocytic leukaemia with brain and spinal cord infiltration"],"prefix":"10.1136","volume":"19","author":[{"given":"Sufia","family":"Ahmed","sequence":"first","affiliation":[{"name":"Internal Medicine Residency, South Pointe Hospital, Cleveland Clinic, Warrensville Heights, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mannem","sequence":"additional","affiliation":[{"name":"Oncology Fellowship, MaineHealth Maine Medical Center, Portland, Maine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[{"name":"Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0207-8770","authenticated-orcid":false,"given":"Chana","family":"Peysin","sequence":"additional","affiliation":[{"name":"Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026081804551877000_19.8.e274800.1","unstructured":"National Comprehensive Cancer Network . NCCB guidelines version 2.2025: chronic lymphocytic leukemia\/small lymphocytic lymphoma. 2025. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf [Accessed 05 Mar 2025]."},{"key":"2026081804551877000_19.8.e274800.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00756-9","article-title":"Chronic lymphocytic leukemia treatment algorithm 2022","volume":"12","author":"Hampel","year":"2022","journal-title":"Blood Cancer J"},{"key":"2026081804551877000_19.8.e274800.3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/JBM.S271335","article-title":"Refractory Chronic Lymphocytic Leukemia with Central Nervous System Involvement: A Case Report with Literature Review","volume":"11","author":"Nakanishi","year":"2020","journal-title":"J Blood Med"},{"key":"2026081804551877000_19.8.e274800.4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.25122\/jml-2024-0321","article-title":"Recurrence of chronic lymphatic leukemia as infiltration of the spinal cord","volume":"17","author":"Finsterer","year":"2024","journal-title":"JMedLife"},{"key":"2026081804551877000_19.8.e274800.5","doi-asserted-by":"crossref","unstructured":"Amado C , Duarte V , Silva Leal M , et al . Chronic Lymphocytic Leukaemia: Rare Involvement of the Central Nervous System. Eur J Case Rep Intern Med 2021;8. doi:10.12890\/2021_002847","DOI":"10.12890\/2021_002847"},{"key":"2026081804551877000_19.8.e274800.6","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/WNO.0000000000001263","article-title":"Optic Perineuritis Presenting as the Initial Manifestation of Central Nervous System Involvement in Rai Stage 0 Chronic Lymphocytic Leukemia","volume":"42","author":"Parker","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"2026081804551877000_19.8.e274800.7","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-249940","article-title":"Symptomatic leptomeningeal carcinomatosis: a rare presentation of chronic lymphocytic leukaemia relapse","volume":"15","author":"Batayneh","year":"2022","journal-title":"BMJ Case Rep"},{"key":"2026081804551877000_19.8.e274800.8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7812\/TPP\/21.081","article-title":"Chronic Lymphocytic Leukemia With Leptomeningeal Involvement Presenting as an Acute Encephalopathy","volume":"26","author":"Bae","year":"2022","journal-title":"Perm J"},{"key":"2026081804551877000_19.8.e274800.9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.6004\/jadpro.2022.13.5.7","article-title":"An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia","volume":"13","author":"Broadway-Duren","year":"2022","journal-title":"J Adv Pract Oncol"},{"key":"2026081804551877000_19.8.e274800.10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hon.3165_495","article-title":"Immunophenotypic characterization of Richter syndrome diffuse large B\u2010cell lymphoma type and comparison with the original chronic lymphocytic leukemia","volume":"41","author":"Martin\u2010Moro","year":"2023","journal-title":"Hematol Oncol"},{"key":"2026081804551877000_19.8.e274800.11","first-page":"1","article-title":"Concurrent neurological involvement in chronic lymphocytic leukemia: a rare case with brain and spinal cord manifestations","volume":"9","author":"Saiedi","year":"2023","journal-title":"Iran J Neurosurg"},{"key":"2026081804551877000_19.8.e274800.12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0619"},{"key":"2026081804551877000_19.8.e274800.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.0852"},{"key":"2026081804551877000_19.8.e274800.14","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.829919"},{"key":"2026081804551877000_19.8.e274800.15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1470-2045(22)00293-5","article-title":"Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial","volume":"23","author":"Tam","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026081804551877000_19.8.e274800.16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fonc.2021.760405","article-title":"Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"2026081804551877000_19.8.e274800.17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4274\/tjh.2017.0313","article-title":"Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib","volume":"35","author":"Christoforidou","year":"2018","journal-title":"Turk J Haematol"},{"key":"2026081804551877000_19.8.e274800.18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.213157"},{"key":"2026081804551877000_19.8.e274800.19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/bloodadvances.2025017755","article-title":"Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL","volume":"10","author":"Chatzikonstantinou","year":"2026","journal-title":"Blood Adv"},{"key":"2026081804551877000_19.8.e274800.20","article-title":"Successful Zanubrutinib Monotherapy in a Rare CNS Presentation of Relapsed CLL","volume":"2026","author":"Kunta","year":"2026","journal-title":"Case Rep Hematol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-274800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:55:26Z","timestamp":1787054126000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-274800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bcr-2026-274800"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-274800","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}